Novartis Digital Medicine This case study explores how novartis executed its digital strategy, what tools and technologies were adopted, and the tangible impact on its business and patients. Leading the digital transformation requires careful planning and visionary leadership. explore how novartis’ leaders drive this long term change.
Novartis Digital Relationship Channel Dezzai Novartis, an industry pioneer, has embarked on an ambitious transformation to become the leading medicines company powered by data science and digital technologies. it knows data are only as good as the tools used to analyze and exploit them. Novartis has launched a digital health innovation lab network named the novartis biome to accelerate its digital evolution. the swiss pharma company will also run a series of open innovation. On the surface, novartis is gaining and maintaining digital attention. with a steady monthly average of 500 mentions of novartis and its main products trials by hcps, peaking at 700 posts during the months of may and june following a series of fda approvals. Discover how novartis is reshaping patient care through telemedicine and digital therapeutics. see what’s driving their success in the evolving digital health space.
Novartis Digital Relationship Channel Dezzai On the surface, novartis is gaining and maintaining digital attention. with a steady monthly average of 500 mentions of novartis and its main products trials by hcps, peaking at 700 posts during the months of may and june following a series of fda approvals. Discover how novartis is reshaping patient care through telemedicine and digital therapeutics. see what’s driving their success in the evolving digital health space. Discover how novartis turns breakthrough science into transformative, high value treatments. learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards. In 2018, novartis set the ambition to become a leading medicines company powered by data and digital technologies. to realize this goal, the newly appointed chief executive officer (ceo), vasant narasimhan, set data and digital leadership as one of novartis’ five strategic priorities. The report provides information and insights into novartis's tech activities, including – • insights of its digital transformation strategies and innovation programs. • overview of technology initiatives covering partnerships, product launches, investments, and acquisitions. Novartis is utilizing digital transformation to enhance drug discovery, to drive efficiency in the development lifecycle, and to improve patient quality of life. digital technology poses a massive opportunity in drug development and patient care.
Comments are closed.